Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas

British Journal of Cancer

Volumn 111, Issue 1, 2014, Pages 132-138

  Singh, Y ^a   Port, J ^a   Schwarz, M ^a   Braeuning, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Connexin 32; Ctnnb1; hepatocellular tumour; human hepatocellular carcinomas; liver; proliferation; Wnt catenin signalling

Indexed keywords

BETA CATENIN; CRE RECOMBINASE; DIETHYLNITROSAMINE; PHENOBARBITAL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; CTNNB1 GENE; GENE; GENE INACTIVATION; GENETIC RECOMBINATION; HEPATOMA CELL; LIVER ADENOMA; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR PROMOTION;

ADENOMA; ANIMALS; BETA CATENIN; CELL GROWTH PROCESSES; GENE KNOCKOUT TECHNIQUES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; WNT SIGNALING PATHWAY;

EID: 84904092798     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.275     Document Type: Article

References (33)

1. Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S, Colnot S, Viguier M, Perret C, Couty JP (2012) Oncogenic betacatenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 122: 586-599.
2. Aydinlik H, Nguyen TD, Moennikes O, Buchmann A, Schwarz M (2001) Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 20: 7812-7816.
3. Braeuning A, Menzel M, Kleinschnitz EM, Harada N, Tamai Y, Köhle C, Buchmann A, Schwarz M (2007) Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes. FEBS J 274: 4766-4777.
4. Braeuning A, Sanna R, Huelsken J, Schwarz M (2009) Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metab Dispos 37: 1138-1145.
5. Braeuning A, Singh Y, Rignall B, Buchmann A, Hammad S, Othman A, von Recklinghausen I, Godoy P, Hoehme S, Drasdo D, Hengstler JG, Schwarz M (2010) Phenotype and growth behavior of residual betacatenin-positive hepatocytes in livers of beta-catenin-deficient mice. Histochem Cell Biol 134: 469-481.
6. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C (2001) Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res 61: 3245-3249.
7. Chafey P, Finzi L, Boisgard R, Cauzac M, Clary G, Broussard C, Pegorier JP, Guillonneau F, Mayeux P, Camoin L, Tavitian B, Colnot S, Perret C (2009) Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics 9: 3889-3900.
8. Chipman JK, Mally A, Edwards GO (2003) Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci 71: 146-153.
9. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851.
10. Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC (1999) Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 18: 4726-4733.
11. Ganzenberg K, Singh Y, Braeuning A (2013) The time point of beta-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor. Toxicology 308: 113-121.
12. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
13. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105: 533-545.
14. Kivistö KT, Villikka K, Nyman L, Anttila M, Neuvonen PJ (1998) Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Clin Pharmacol Ther 64: 648-654.
15. Kumar NM, Gilula NB (1996) The gap junction communication channel. Cell 84: 381-388.
16. Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M (2002) Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res 62: 5685-5688.
17. Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK\+ precursors. Hum Pathol 40: 783-794.
18. Lustig B, Behrens J (2003) The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129: 199-221.
19. Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W, Huelsken J (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 452: 650-653.
20. Marx-Stoelting P, Mahr J, Knorpp T, Schreiber S, Templin MF, Ott T, Buchmann A, Schwarz M (2008) Tumor promotion in liver of mice with a conditional Cx26 knockout. Toxicol Sci 103: 260-267.
21. Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M (2000) Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res 60: 5087-5091.
22. Orford K, Orford CC, Byers SW (1999) Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 146: 855-868.
23. Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C (1999) Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59: 3875-3879.
24. Schmidt A, Braeuning A, Ruck P, Seitz G, Armeanu-Ebinger S, Fuchs J, Warmann SW, Schwarz M (2011) Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma. Toxicology 281: 7-14.
25. Scholer-Dahirel A, Schlabach MR, Loo A, Bagdasarian L, Meyer R, Guo R, Woolfenden S, Yu KK, Markovits J, Killary K, Sonkin D, Yao YM, Warmuth M, Sellers WR, Schlegel R, Stegmeier F, Mosher RE, McLaughlin ME (2011) Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 108: 17135-17140.
26. Shang XZ, Zhu H, Lin K, Tu Z, Chen J, Nelson DR, Liu C (2004) Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalphainduced apoptosis. Lab Invest 84: 332-341.
27. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278: 120-123.
28. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527.
29. Singh Y, Braeuning A, Schmid A, Pichler BJ, Schwarz M (2013) Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen. Arch Toxicol 87: 1595-1607.
30. Stahl S, Ittrich C, Marx-Stoelting P, Kohle C, Altug-Teber O, Riess O, Bonin M, Jobst J, Kaiser S, Buchmann A, Schwarz M (2005) Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 42: 353-361.
31. Tannour-Louet M, Porteu A, Vaulont S, Kahn A, Vasseur-Cognet M (2002) A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35: 1072-1081.
32. Yamasaki H, Naus CC (1996) Role of connexin genes in growth control. Carcinogenesis 17: 1199-1213.
33. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM (2001) Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667.